Joseph Catanzaro
Stock Analyst at Mizuho Securities
Total Price Targets
30
Stocks Covered
19
Sectors
Healthcare
Most Recent
Apr 15, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Joseph Catanzaro
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | $18.00 | $8.97 | +100.7% | 1 | Apr 15, 2026 |
| UPB | Upstream Bio, Inc. | $51.00 | $9.31 | +447.8% | 1 | Dec 17, 2025 |
| AVTX | Avalo Therapeutics, Inc. | $39.00 | $13.63 | +186.2% | 1 | Dec 17, 2025 |
| BCAX | Bicara Therapeutics Inc. Common Stock | $18.00 | $21.90 | -17.8% | 1 | Dec 17, 2025 |
| IOVA | Iovance Biotherapeutics, Inc. | $7.50 | $3.40 | +120.3% | 4 | Jan 31, 2025 |
| HALO | Halozyme Therapeutics, Inc. | $52.00 | $64.04 | -18.8% | 2 | Nov 15, 2024 |
| CTMX | CytomX Therapeutics, Inc. | $3.25 | $4.16 | -21.8% | 2 | Nov 8, 2024 |
| RVMD | Revolution Medicines, Inc. | $70.00 | $140.52 | -50.2% | 2 | Nov 7, 2024 |
| GILD | Gilead Sciences, Inc. | $105.00 | $132.04 | -20.5% | 2 | Nov 7, 2024 |
| BMEA | Biomea Fusion, Inc. | $19.00 | $1.36 | +1291.9% | 2 | Oct 31, 2024 |
| EXEL | Exelixis, Inc. | $36.00 | $43.81 | -17.8% | 1 | Oct 30, 2024 |
| TNGX | Tango Therapeutics, Inc. | $18.00 | $20.95 | -14.1% | 1 | Sep 17, 2024 |
| LENZ | LENZ Therapeutics, Inc. | $36.00 | $8.85 | +307.0% | 1 | Aug 15, 2024 |
| KROS | Keros Therapeutics, Inc. | $105.00 | $11.48 | +814.6% | 2 | Jun 18, 2024 |
| CNTX | Context Therapeutics Inc. | $4.50 | $2.31 | +95.2% | 1 | May 16, 2024 |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $30.00 | $2.05 | +1363.4% | 2 | Apr 25, 2024 |
| DAWN | Day One Biopharmaceuticals, Inc. | $45.00 | $21.50 | +109.3% | 2 | Jan 8, 2023 |
| CPRX | Catalyst Pharmaceuticals, Inc. | $20.00 | $28.77 | -30.5% | 1 | Dec 19, 2022 |
| OCUL | Ocular Therapeutix, Inc. | $10.00 | $9.46 | +5.7% | 1 | Jun 7, 2022 |
Recent Activity
- Apr 15, 2026— Set$18.00price target onCLYM(Climb Bio, Inc.)
- Dec 17, 2025— Set$51.00price target onUPB(Upstream Bio, Inc.)
- Dec 17, 2025— Set$39.00price target onAVTX(Avalo Therapeutics, Inc.)
- Dec 17, 2025— Set$18.00price target onBCAX(Bicara Therapeutics Inc. Common Stock)
- Jan 31, 2025— Set$7.50price target onIOVA(Iovance Biotherapeutics, Inc.)
- Nov 15, 2024— Set$52.00price target onHALO(Halozyme Therapeutics, Inc.)
- Nov 8, 2024— Set$3.25price target onCTMX(CytomX Therapeutics, Inc.)
- Nov 7, 2024— Set$105.00price target onGILD(Gilead Sciences, Inc.)
- Nov 7, 2024— Set$70.00price target onRVMD(Revolution Medicines, Inc.)
- Oct 31, 2024— Set$19.00price target onBMEA(Biomea Fusion, Inc.)
- Oct 30, 2024— Set$36.00price target onEXEL(Exelixis, Inc.)
- Sep 27, 2024— Set$10.00price target onBMEA(Biomea Fusion, Inc.)
- Sep 17, 2024— Set$57.00price target onRVMD(Revolution Medicines, Inc.)
- Sep 17, 2024— Set$18.00price target onTNGX(Tango Therapeutics, Inc.)
- Sep 11, 2024— Set$95.00price target onGILD(Gilead Sciences, Inc.)
- Aug 15, 2024— Set$36.00price target onLENZ(LENZ Therapeutics, Inc.)
- Jul 29, 2024— Set$10.00price target onIOVA(Iovance Biotherapeutics, Inc.)
- Jun 18, 2024— Set$105.00price target onKROS(Keros Therapeutics, Inc.)
- Jun 7, 2024— Set$51.00price target onHALO(Halozyme Therapeutics, Inc.)
- May 27, 2024— Set$3.50price target onCTMX(CytomX Therapeutics, Inc.)
Frequently Asked Questions
Who is Joseph Catanzaro?
Joseph Catanzaro is a stock analyst at Mizuho Securities covering 19 stocks primarily in Healthcare. They have issued 30 price targets since May 18, 2022.
What stocks does Joseph Catanzaro cover?
Joseph Catanzaro currently covers 19 stocks, including IOVA, HALO, CTMX, RVMD, GILD.
What is Joseph Catanzaro's latest price target?
Joseph Catanzaro's most recent price target was $18.00 on CLYM (Climb Bio, Inc.), set on Apr 15, 2026.
What is Joseph Catanzaro's highest price target?
Joseph Catanzaro's highest issued price target is $120.00 on KROS, set on May 18, 2022.
More Analysts at Mizuho Securities
Coverage based on publicly published price targets. Not investment advice.